Aspirin may decrease the risk for developing high-grade prostate cancer
the ONA take:
According to new findings presented at the 13th Annual American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research in New Orleans, Louisiana, the use of aspirin and other other non-steroidal anti-inflammatory drugs (NSAIDs) were associated with a decreased risk for developing an aggressive form of prostate cancer in patients who had a negative biopsy despite an increased prostate specific antigen (PSA).
The researchers used patients from the REDUCE trial, which studied if dutasteride, a 5-alpha reductase inhibitor, lowers the risk for developing prostate cancer.
Of the 6,390 participants with a PSA between 2.5 ng/mL and 10 ng/mL and a negative biopsy prior to the study, 50% were aspirin/NSAID nonusers, 21% were aspirin users, 18% were NSAID users, and 11% were users of both drugs. They found that aspirin and/or NSAID use decreased the risk for developing prostate cancer by 14%, and after adjusting for confounding factors, 13%.
Furthermore, they found that aspirin and/or NSAID use lowered the risk of high-grade disease by 17%. No link was observed with low-grade prostate cancer. Results were similar among patients from different continents.
Aspirin and other other NSAIDs were associated with a decreased risk for aggressive prostate cancer.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- Overall Survival Prolonged With HIPEC + Cytoreductive Surgery for Gastric Cancer
- Better Postoperative Outcomes With RAMIE for Esophageal Cancer
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|